The role of “anti-inflammatory” cytokines in axon regeneration

Goldsby, 2000, Kuby Immunology

Sholl-Franco, 2009, Interleukin-4 as a neuromodulatory cytokine: roles and signaling in the nervous system, Annals of the New York Academy of Sciences, 1153, 65, 10.1111/j.1749-6632.2008.03962.x

Besser, 1999, Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors, Journal of Immunology, 162, 6303, 10.4049/jimmunol.162.11.6303

Kelly-Welch, 2003, Interleukin-4 and interleukin-13 signaling connections maps, Science, 300, 1527, 10.1126/science.1085458

Gilman, 2001, Goodman & Gilman's the Pharmacological Basis of Therapeutics

Hendrix, 2007, The role of T helper cells in neuroprotection and regeneration, Journal of Neuroimmunology, 184, 100, 10.1016/j.jneuroim.2006.11.019

Bethea, 1998, Traumatic spinal cord injury induces nuclear factor-kappaB activation, Journal of Neuroscience, 18, 3251, 10.1523/JNEUROSCI.18-09-03251.1998

Maini, 2000, Anti-cytokine therapy for rheumatoid arthritis, Annual Review of Medicine, 51, 207, 10.1146/annurev.med.51.1.207

Opal, 2000, Anti-inflammatory cytokines, Chest, 117, 1162, 10.1378/chest.117.4.1162

Matzinger, 2007, Friendly and dangerous signals: is the tissue in control?, Nature Immunology, 8, 11, 10.1038/ni0107-11

Yiu, 2006, Glial inhibition of CNS axon regeneration, Nature Reviews Neuroscience, 7, 617, 10.1038/nrn1956

Tom, 2004, Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury, Journal of Neuroscience, 24, 6531, 10.1523/JNEUROSCI.0994-04.2004

Ming, 2002, Adaptation in the chemotactic guidance of nerve growth cones, Nature, 417, 411, 10.1038/nature745

Moalem, 1999, Differential T cell response in central and peripheral nerve injury: connection with immune privilege, FASEB Journal, 13, 1207, 10.1096/fasebj.13.10.1207

Donnelly, 2008, Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury, Experimental Neurology, 209, 378, 10.1016/j.expneurol.2007.06.009

Bethea, 1999, Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats, Journal of Neurotrauma, 16, 851, 10.1089/neu.1999.16.851

Pineau, 2007, Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved, Journal of Comparative Neurology, 500, 267, 10.1002/cne.21149

Schwab, 2006, Experimental strategies to promote spinal cord regeneration—an integrative perspective, Progress in Neurobiology, 78, 91, 10.1016/j.pneurobio.2005.12.004

Beck, 2010, Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment, Brain, 133, 433, 10.1093/brain/awp322

Ankeny, 2006, Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis, Journal of Neurochemistry, 99, 1073, 10.1111/j.1471-4159.2006.04147.x

Bonilla, 2002, Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth, Journal of Neuroscience, 22, 1303, 10.1523/JNEUROSCI.22-04-01303.2002

Schwab, 2005, Injury-related dynamic myelin/oligodendrocyte axon-outgrowth inhibition in the central nervous system, Lancet, 365, 2055, 10.1016/S0140-6736(05)66699-8

Molina-Holgado, 2001, LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10, European Journal of Neuroscience, 13, 493, 10.1046/j.0953-816x.2000.01412.x

Wolf, 2002, Neuroprotection by T-cells depends on their subtype and activation state, Journal of Neuroimmunology, 133, 72, 10.1016/S0165-5728(02)00367-3

Deboy, 2006, Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells, Experimental Neurology, 201, 212, 10.1016/j.expneurol.2006.04.028

Koeberle, 2004, Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells, Neuroscience, 125, 903, 10.1016/S0306-4522(03)00398-1

Araujo, 1993, Trophic effects of interleukin-4-7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors, Brain Research, 600, 49, 10.1016/0006-8993(93)90400-H

Araujo, 1995, Differential effects of interleukin-1 beta and interleukin-2 on glia and hippocampal neurons in culture, International Journal of Developmental Neuroscience, 13, 201, 10.1016/0736-5748(94)00072-B

Fok-Seang, 1998, Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth, European Journal of Neuroscience, 10, 2400, 10.1046/j.1460-9568.1998.00251.x

Dhabhar, 2009, Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology, Neuroimmunomodulation, 16, 300, 10.1159/000216188

Sempowski, 1994, Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors, role of IL-4 in enhancing fibroblast proliferation and collagen synthesis, Journal of Immunology, 152, 3606, 10.4049/jimmunol.152.7.3606

Toi, 1992, Inhibition of colon and breast carcinoma cell growth by interleukin-4, Cancer Research, 52, 275

Obiri, 1994, Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells, Oncology Research, 6, 419

Yang, 2005, Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice, Journal of Pharmacology and Experimental Therapeutics, 313, 8, 10.1124/jpet.104.076133

Hahn, 2003, Inhibition of the IL-4/IL-13 receptor system prevents allergic sensitization without affecting established allergy in a mouse model for allergic asthma, Journal of Allergy and Clinical Immunology, 111, 1361, 10.1067/mai.2003.1527

Cua, 1999, Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis, Journal of Experimental Medicine, 189, 1005, 10.1084/jem.189.6.1005

Lu, 2005, The temporal effects of anti-TGF-beta1 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation, Journal of the American College of Surgeons, 201, 391, 10.1016/j.jamcollsurg.2005.03.032

Cai, 2000, Effects of leukaemia inhibitory factor on embryo implantation in the mouse, Cytokine, 12, 1676, 10.1006/cyto.2000.0758

Paludan, 1997, Effect of IL-4 and IL-13 on IFN-gamma-induced production of nitric oxide in mouse macrophages infected with herpes simplex virus type 2, FEBS Letters, 414, 61, 10.1016/S0014-5793(97)00987-3

Szczepanik, 2001, IL-4, IL-10 and IL-13 modulate A beta(1–42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line, Neuroimmunol, 113, 49, 10.1016/S0165-5728(00)00404-5

Cash, 1994, Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats, Journal of Immunology, 153, 4258, 10.4049/jimmunol.153.9.4258

Wang, 2006, Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE, Neurochem, 98, 1817, 10.1111/j.1471-4159.2006.04081.x

Sicotte, 2003, Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord, Molecular and Cellular Neurosciences, 23, 251, 10.1016/S1044-7431(03)00053-8

Gimsa, 2001, Th2 cells support intrinsic anti-inflammatory properties of the brain, Journal of Neuroimmunology, 119, 73, 10.1016/S0165-5728(01)00343-5

Golz, 2006, The cytokine/neurotrophin axis in peripheral axon outgrowth, European Journal of Neuroscience, 24, 2721, 10.1111/j.1460-9568.2006.05155.x

Uceyler, 2007, Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain, Brain, Behavior, and Immunity, 21, 553, 10.1016/j.bbi.2006.10.003

Uceyler, 2008, Early cytokine gene expression in mouse CNS after peripheral nerve lesion, Neuroscience Letters, 436, 259, 10.1016/j.neulet.2008.03.037

Sholl-Franco, 2001, Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture, Neuroreport, 12, 109, 10.1097/00001756-200101220-00029

Toi, 1991, Interleukin-4 is a potent mitogen for capillary endothelium, Biochemical and Biophysical Research Communications, 174, 1287, 10.1016/0006-291X(91)91561-P

Volpert, 1998, Inhibition of angiogenesis by interleukin 4, Exp Med, 188, 1039, 10.1084/jem.188.6.1039

Sekimoto, 2003, Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cells, Immunology Letters, 88, 221, 10.1016/S0165-2478(03)00080-4

Figurov, 1996, Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus, Nature, 381, 706, 10.1038/381706a0

Lee, 2010, Endogenous expression of interleukin-4 regulates macrophage activation and confines cavity formation after traumatic spinal cord injury, Journal of Neuroscience Research, 88, 2409, 10.1002/jnr.22411

Adao-Novaes, 2009, Interleukin-4 blocks thapsigargin-induced cell death in rat rod photoreceptors: involvement of cAMP/PKA pathway, Journal of Neuroscience Research, 87, 2167, 10.1002/jnr.22026

Sholl-Franco, 2002, IL-4 increases GABAergic phenotype in rat retinal cell cultures: involvement of muscarinic receptors and protein kinase C, Journal of Neuroimmunology, 133, 20, 10.1016/S0165-5728(02)00327-2

Sawada, 1995, Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells, International Journal of Developmental Neuroscience, 13, 253, 10.1016/0736-5748(94)00076-F

Chao, 1993, Neuroprotective role of IL-4 against activated microglia, Journal of Immunology, 151, 1473, 10.4049/jimmunol.151.3.1473

Brodie, 1998, Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion, Journal of Neuroimmunology, 81, 20, 10.1016/S0165-5728(97)00154-9

Merril, 1997, Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes, Journal of Neuroscience Research, 48, 372, 10.1002/(SICI)1097-4547(19970515)48:4<372::AID-JNR9>3.0.CO;2-8

Butovsky, 2006, Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells, Molecular and Cellular Neurosciences, 31, 149, 10.1016/j.mcn.2005.10.006

Xin, 2008, Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy, Brain, Behavior, and Immunity, 22, 528, 10.1016/j.bbi.2007.10.006

Xin, 2011, IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection, Brain, Behavior, and Immunity, 25, 820, 10.1016/j.bbi.2010.08.004

Atkins, 2007, Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repair, Journal of the Peripheral Nervous System, 12, 269, 10.1111/j.1529-8027.2007.00148.x

Boyd, 2003, Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress, Investigative Ophthalmology and Visual Science, 44, 5206, 10.1167/iovs.03-0534

Kaltschmidt, 1995, Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons, Proceedings of the National Academy of Sciences of the United States of America, 92, 9618, 10.1073/pnas.92.21.9618

Gill, 2000, Ceramide initiates NFkappaB-mediated caspase activation in neuronal apoptosis, Neurobiology of Disease, 7, 448, 10.1006/nbdi.2000.0312

Bachis, 2001, Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity, Journal of Neuroscience, 21, 3104, 10.1523/JNEUROSCI.21-09-03104.2001

Schottelius, 1999, Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding, Journal of Biological Chemistry, 274, 31868, 10.1074/jbc.274.45.31868

Dietrich, 1999, Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats, Experimental Neurology, 158, 444, 10.1006/exnr.1999.7115

Pahan, 2000, Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase, Journal of Neurochemistry, 75, 576, 10.1046/j.1471-4159.2000.0750576.x

Strle, 2002, IL-10 promotes survival of microglia without activating Akt, Journal of Neuroimmunology, 122, 9, 10.1016/S0165-5728(01)00444-1

Knoblach, 1998, Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury, Experimental Neurology, 153, 143, 10.1006/exnr.1998.6877

Grilli, 2000, Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage, European Journal of Neuroscience, 12, 2265, 10.1046/j.1460-9568.2000.00090.x

Zhou, 2009, IL-10 promotes neuronal survival following spinal cord injury, Experimental Neurology, 220, 183, 10.1016/j.expneurol.2009.08.018

Zhou, 2009, Interleukin-10 provides direct trophic support to neurons, Journal of Neurochemistry, 110, 1617, 10.1111/j.1471-4159.2009.06263.x

Takami, 2002, Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome, Journal of Neurotrauma, 19, 653, 10.1089/089771502753754118

Hershey, 2003, IL-13 receptors and signaling pathways: an evolving web, Journal of Allergy and Clinical Immunology, 111, 677, 10.1067/mai.2003.1333

Doherty, 1993, Modulation of murine macrophage function by IL-13, Journal of Immunology, 151, 7151, 10.4049/jimmunol.151.12.7151

Shin, 2004, Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo, Glia, 46, 142, 10.1002/glia.10357

Yang, 2006, Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: implications for death of activated microglia, Journal of Immunology, 177, 1323, 10.4049/jimmunol.177.2.1323

Yang, 2002, Interleukin-13 and -4 induce death of activated microglia, Glia, 38, 273, 10.1002/glia.10057

Park, 2009, IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo, Journal of Immunology, 183, 4666, 10.4049/jimmunol.0803392

Iadecola, 2001, Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice, Proceedings of the National Academy of Sciences of the United States of America, 98, 1294, 10.1073/pnas.98.3.1294

Sakamoto, 1995, Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage, Blood, 85, 3487, 10.1182/blood.V85.12.3487.bloodjournal85123487

Defrance, 1994, Interleukin 13 is a B cell stimulating factor, Journal of Experimental Medicine, 179, 135, 10.1084/jem.179.1.135

Zurawski, 1994, Interleukin 13 elicits a subset of the activities of its close relative interleukin 4, Stem Cells, 12, 169, 10.1002/stem.5530120204

Avellino, 1995, Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons, Experimental Neurology, 136, 183, 10.1006/exnr.1995.1095

Slaets, 2010, Therapeutic potential of LIF in multiple sclerosis, Trends in Molecular Medicine, 16, 493, 10.1016/j.molmed.2010.08.007

Hendry, 1992, Binding and retrograde transport of leukemia inhibitory factor by the sensory nervous system, Journal of Neuroscience, 12, 3427, 10.1523/JNEUROSCI.12-09-03427.1992

Curtis, 1994, Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve, Neuron, 12, 191, 10.1016/0896-6273(94)90163-5

Tham, 1997, Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle, Journal of Neuroscience Research, 47, 208, 10.1002/(SICI)1097-4547(19970115)47:2<208::AID-JNR9>3.0.CO;2-J

Curtis, 1993, Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury, Nature, 365, 253, 10.1038/365253a0

Murphy, 1991, Generation of sensory neurons is stimulated by leukemia inhibitory factor, Proceedings of the National Academy of Sciences of the United States of America, 88, 3498, 10.1073/pnas.88.8.3498

Cafferty, 2001, Leukemia inhibitory factor determines the growth status of injured adult sensory neurons, Journal of Neuroscience, 21, 7161, 10.1523/JNEUROSCI.21-18-07161.2001

Blesch, 1999, Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury, Journal of Neuroscience, 19, 3556, 10.1523/JNEUROSCI.19-09-03556.1999

Sugiura, 2000, Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro, European Journal of Neuroscience, 12, 457, 10.1046/j.1460-9568.2000.00922.x

Ransome, 2008, Erythropoietin promotes axonal growth in a model of neuronal polarization, Molecular and Cellular Neurosciences, 38, 537, 10.1016/j.mcn.2008.05.002

Au, 2007, SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair, Journal of Neuroscience, 27, 7208, 10.1523/JNEUROSCI.0509-07.2007

Lindholm, 1992, Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation, Journal of Cell Biology, 117, 395, 10.1083/jcb.117.2.395

Kohta, 2009, Inhibition of TGF-beta1 promotes functional recovery after spinal cord injury, Neuroscience Research, 65, 393, 10.1016/j.neures.2009.08.017

Asher, 2000, Neurocan is upregulated in injured brain and in cytokine-treated astrocytes, Journal of Neuroscience, 20, 2427, 10.1523/JNEUROSCI.20-07-02427.2000

Schachtrup, 2010, Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage, Journal of Neuroscience, 30, 5843, 10.1523/JNEUROSCI.0137-10.2010

Makwana, 2007, Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS, Journal of Neuroscience, 27, 11201, 10.1523/JNEUROSCI.2255-07.2007

Moon, 2001, Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2, European Journal of Neuroscience, 14, 1667, 10.1046/j.0953-816x.2001.01795.x

Kimura-Kuroda, 2010, An in vitro model of the inhibition of axon growth in the lesion scar formed after central nervous system injury, Molecular and Cellular Neurosciences, 43, 177, 10.1016/j.mcn.2009.10.008

McTigue, 2000, Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury, Experimental Neurology, 163, 220, 10.1006/exnr.2000.7372

Jones, 2002, Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy, Journal of Neuroscience, 22, 2690, 10.1523/JNEUROSCI.22-07-02690.2002

Rotshenker, 2011, Wallerian degeneration: the innate-immune response to traumatic nerve injury, J Neuroinflammation, 8, 109, 10.1186/1742-2094-8-109

Aharoni, 2003, Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ, Proceedings of the National Academy of Sciences of the United States of America, 100, 14157, 10.1073/pnas.2336171100

Noga, 2007, Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor, Clinical and Experimental Allergy, 37, 1701, 10.1111/j.1365-2222.2007.02832.x

Sin, 2001, Nerve growth factor or IL-3 induces more IL-13 production from basophils of allergic subjects than from basophils of nonallergic subjects, Journal of Allergy and Clinical Immunology, 108, 387, 10.1067/mai.2001.117459

De Simone, 2007, NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-beta, Journal of Neuroimmunology, 190, 53, 10.1016/j.jneuroim.2007.07.020

Marzella, 1998, Synergy between TGF-beta 3 and NT-3 to promote the survival of spiral ganglia neurones in vitro, Neuroscience Letters, 240, 77, 10.1016/S0304-3940(97)00928-2

Marzella, 1999, The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro, Hearing Research, 138, 73, 10.1016/S0378-5955(99)00152-5

Yelo, 2008, Dock10, a novel CZH protein selectively induced by interleukin-4 in human B lymphocytes, Molecular Immunology, 45, 3411, 10.1016/j.molimm.2008.04.003

Chiba, 2009, Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein, American Journal of Respiratory Cell and Molecular Biology, 40, 159, 10.1165/rcmb.2008-0162OC

Chen, 2009, Rho-mediated regulation of TGF-beta1- and FGF-2-induced activation of corneal stromal keratocytes, Investigative Ophthalmology and Visual Science, 50, 3662, 10.1167/iovs.08-3276

Lee, 2008, Rho plays a key role in TGF-beta1-induced cytoskeletal rearrangement in human retinal pigment epithelium, Journal of Cellular Physiology, 216, 520, 10.1002/jcp.21424

Xiao, 2008, Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells, Journal of Immunology, 181, 3575, 10.4049/jimmunol.181.5.3575

Ethier, 2005, Mechanisms of interleukin-4 effects on calcium signaling in airway smooth muscle cells, Journal of Pharmacology and Experimental Therapeutics, 313, 127, 10.1124/jpet.104.079343

Martin, 2008, Interleukin-4 activates large-conductance, calcium-activated potassium (BKCa) channels in human airway smooth muscle cells, Experimental Physiology, 93, 908, 10.1113/expphysiol.2008.042432

Park-Min, 2009, IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression, Journal of Immunology, 183, 2444, 10.4049/jimmunol.0804165

Miki, 2010, Transforming growth factor beta1 alters calcium mobilizing properties and endogenous ATP release in A549 cells: possible implications for cell migration, Journal of Pharmacological Sciences, 113, 387, 10.1254/jphs.10124FP

Faon, 2006, Increased secretion of leukemia inhibitory factor by immature airway smooth muscle cells enhances intracellular signaling and airway contractility, American Journal of Physiology. Lung Cellular and Molecular Physiology, 291, L244, 10.1152/ajplung.00474.2005

Dugas, 1995, IL-4 induces cAMP and cGMP in human monocytic cells, Mediators of Inflammation, 4, 298, 10.1155/S0962935195000482

Kambayashi, 2001, cAMP-elevating agents suppress dendritic cell function, Journal of Leukocyte Biology, 70, 903, 10.1189/jlb.70.6.903

Wei, 2000, IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells, American Journal of Physiology. Cell Physiology, 279, C248, 10.1152/ajpcell.2000.279.1.C248

Chang, 2000, The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production, Journal of Immunology, 165, 2134, 10.4049/jimmunol.165.4.2134

Son, 2010, cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction, Biochemical and Biophysical Research Communications, 398, 309, 10.1016/j.bbrc.2010.06.087

Howe, 2002, TGF-beta effects on epithelial ion transport and barrier: reduced Cl- secretion blocked by a p38 MAPK inhibitor, American Journal of Physiology. Cell Physiology, 283, C1667, 10.1152/ajpcell.00414.2001

Nesti, 2007, TGF-beta1 calcium signaling in osteoblasts, Journal of Cellular Biochemistry, 101, 348, 10.1002/jcb.21180

Cai, 1999, Transforming growth factor-beta1 and glial growth factor 2 reduce neurotrophin-3 mRNA expression in cultured Schwann cells via a cAMP-dependent pathway, Brain Research. Molecular Brain Research, 71, 256, 10.1016/S0169-328X(99)00200-4

Latijnhouwers, 1998, Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway, Matrix Biology, 17, 305, 10.1016/S0945-053X(98)90083-X

Jinnin, 2006, Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways, Journal of Investigative Dermatology, 126, 551, 10.1038/sj.jid.5700090

White, 2001, Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle, Cell and Tissue Research, 306, 129, 10.1007/s004410100432

Ishibashi, 2009, Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve, Journal of Neuroscience Research, 87, 3343, 10.1002/jnr.22173

Tadagavadi, 2010, Netrin-1 regulates Th1/Th2/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury, Journal of Immunology, 185, 3750, 10.4049/jimmunol.1000435

Mutz, 2010, The neuronal guidance protein netrin-1 reduces alveolar inflammation in a porcine model of acute lung injury, Critical Care, 14, R189, 10.1186/cc9301

Kim, 2006, Transforming growth factor-beta1 regulates macrophage migration via RhoA, Blood, 108, 1821, 10.1182/blood-2005-10-009191

He, 2008, Antiinflammatory effect of Rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritis, Arthritis and Rheumatism, 58, 3366, 10.1002/art.23986

Feske, 2001, Gene regulation mediated by calcium signals in T lymphocytes, Nature Immunology, 2, 316, 10.1038/86318

Zhang, 2008, Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages, Journal of Immunology, 181, 5015, 10.4049/jimmunol.181.7.5015

Fisher, 2001, Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells, Journal of Biological Chemistry, 276, 5967, 10.1074/jbc.M009781200

Liu, 2010, mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion, Developmental Cell, 19, 845, 10.1016/j.devcel.2010.11.004

Cantarella, 2002, Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo, FASEB Journal, 16, 1307, 10.1096/fj.01-1000fje

Nassenstein, 2003, The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma, Journal of Experimental Medicine, 198, 455, 10.1084/jem.20010897

Huang, 2010, Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression, Journal of Immunology, 185, 1450, 10.4049/jimmunol.0901352

Garci-Nieto, 2010, Laminin and fibronectin treatment leads to generation of dendritic cells with superior endocytic capacity, PLoS One, 5, e10123, 10.1371/journal.pone.0010123

Brewer, 1999, Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury, Experimental Neurology, 159, 484, 10.1006/exnr.1999.7173